Search

Your search keyword '"Frise, Rebecca"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Frise, Rebecca" Remove constraint Author: "Frise, Rebecca"
36 results on '"Frise, Rebecca"'

Search Results

3. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults

4. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets

7. A Rapid, Portable, and Electricity-Free Sample Extraction Method for Enhanced Molecular Diagnostics in Resource-Limited Settings

9. Evaluation of a human mucosal tissue explant model for SARS-CoV-2 replication

11. Omicron breakthrough infections in vaccinated or previously infected hamsters.

13. Species difference in ANP32A underlies influenza A virus polymerase host restriction

14. A self-amplifying RNA vaccine protects against SARS-CoV-2 (D614G) and Alpha variant of concern (B.1.1.7) in a transmission-challenge hamster model

15. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge

16. Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway

18. Mutations that adapt SARS-CoV-2 to mustelid hosts do not increase fitness in the human airway.

19. Favipiravir-resistant influenza A virus shows potential for transmission

20. Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model

21. SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study

22. The furin cleavage site of SARS-CoV-2 spike protein is a key determinant for transmission due to enhanced replication in airway cells

23. Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model

25. Favipiravir-resistant influenza A virus shows potential for transmission

26. Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey

27. Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission

30. Regulation of influenza A virus mRNA splicing by CLK1

31. RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals

33. Internal genes of a highly pathogenic H5N1 influenza virus determine high viral replication in myeloid cells and severe outcome of infection in mice

34. RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals.

35. Contact transmission of influenza virus between ferrets imposes a looser bottleneck than respiratory droplet transmission allowing propagation of antiviral resistance

Catalog

Books, media, physical & digital resources